Cuprina Holdings
Singapore-based MedTech company that specialises in the development of products to treat chronic wounds. MEDIFLY, a bio-dressing made of live, medical-grade maggots, is used by private and public hospitals in Singapore and Hong Kong to disinfect and debride chronic wounds, known as Maggot Debridement Therapy (MDT). Our product is clinically-proven to reduce amputation rates and eliminate infections in chronic wounds, especially diabetic foot ulcers and pressure ulcers. We are ISO13485 certified and our MEDIFLY products are HSA registered as class C medical devices.
Cuprina develops bio-dressing using ‘maggot debridement therapy'
The biotech’s product, MEDIFLY, is an innovative approach to help eliminate necrotic tissues in wounds.
Cuprina develops bio-dressing using ‘maggot debridement therapy'
The biotech’s product, MEDIFLY, is an innovative approach to help eliminate necrotic tissues in wounds.
Resource Center
Read Here
Advertise
Sign Up
Event News
Only one of two leading firms achieves 80% of their digital transformation project targets.
